Duoneb and Intervertebral disc space narrowing - a phase IV clinical study of FDA data

Summary:

Intervertebral disc space narrowing is reported as a side effect among people who take Duoneb (albuterol sulfate; ipratropium bromide), especially for people who are female, 50-59 old, also take Coumadin, and have Cataplexy.

The phase IV clinical study analyzes which people have Intervertebral disc space narrowing when taking Duoneb. It is created by eHealthMe based on reports of 8,008 people who have side effects when taking Duoneb from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Intervertebral disc space narrowing?

Intervertebral disc space narrowing (spinal disc space narrowing) is found to be associated with 452 drugs and 315 conditions by eHealthMe. Check the latest studies of Intervertebral disc space narrowing.

On Jul, 15, 2026

8,008 people reported to have side effects when taking Duoneb.
Among them, 15 people (0.19%) have Intervertebral disc space narrowing.

Could Duoneb cause Intervertebral disc space narrowing?

Among these 15 people:

What is the gender of people who have Intervertebral disc space narrowing when taking Duoneb? *

female: 93.33 %
male: 6.67 %

What is the age of people who have Intervertebral disc space narrowing when taking Duoneb? *

What are other drugs people take besides Duoneb? *

What are other side effects people have besides Intervertebral disc space narrowing? *

Intervertebral Disc Protrusion (spinal disc protrusion): 15 people, 100.00%
Fatigue (feeling of tiredness): 15 people, 100.00%
Pain: 15 people, 100.00%
Stress And Anxiety: 15 people, 100.00%
Chest Pain: 15 people, 100.00%
Depression: 14 people, 93.33%
Cough: 13 people, 86.67%
Weakness: 11 people, 73.33%
Leukocytosis (increased white blood cells): 11 people, 73.33%
International Normalised Ratio Increased: 11 people, 73.33%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 26.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 26.67%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 6.67%
Cardiac Failure Congestive: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and have Intervertebral disc space narrowing?

- Check whether Intervertebral disc space narrowing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duoneb:

Duoneb (8,093 reports)

Intervertebral disc space narrowing treatments and more:

Intervertebral disc space narrowing (1,486 reports)

How severe was Intervertebral disc space narrowing and when was it recovered:

Intervertebral disc space narrowing in Duoneb

Expand to all the drugs that have ingredients of albuterol sulfate; ipratropium bromide:

Intervertebral disc space narrowing and drugs with ingredients of albuterol sulfate; ipratropium bromide

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc space narrowing:

Intervertebral disc space narrowing (452 drugs)

Browse all the conditions that are associated with Intervertebral disc space narrowing:

Intervertebral disc space narrowing (315 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Duoneb) and Duoneb (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.